Peers of Outlook Therapeutics Inc (OTLK)
Side-by-side comparison
Free AI scores & summaries library
Health Care · Biotechnology
Enterprise value divided by sales over the last 12 months. Like P/S, but also accounts for the company’s debt and cash.
Latest EV/Sales
460.23x
As of Jun 29, 2026
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Jun 29, 2026 | 460.23x |
| Jun 26, 2026 | 465.15x |
| Jun 25, 2026 | 440.53x |
| Jun 24, 2026 | 457.76x |
| Jun 23, 2026 | 462.69x |
| Jun 22, 2026 | 494.70x |
| Jun 18, 2026 | 433.14x |
| Jun 17, 2026 | 450.38x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison